Cardiomyopathy News and Research

RSS

Cardiomyopathy is a group of diseases with primary, usually diffuse, involvement of the myocardium. The myocardial disease is not secondary to ischaemic, valvular, congenital or pericardial disease.

Most women with heart disease can shun advice to avoid pregnancy

The majority of women with structural or ischemic heart disease can safely undergo pregnancy with extensive pre-evaluation and high-quality care, say researchers.

18 Sep 2012

Plastic hearts still break

Renewal of cells in the human heart occurs throughout life and is boosted by, but cannot prevent, the effects of aging and cardiomyopathy, a study shows.

18 Sep 2012

Friedreich Ataxia Research Alliance, USF ARC to host ‘Understanding a Cure’ symposium

Scientists, clinicians and patients will gather at the University of South Florida's Center for Advanced Medical Learning and Simulation (CAMLS) in downtown Tampa Sept. 6 to share research insights and energize the search for a cure for Friedreich's ataxia and related disorders.

28 Aug 2012

Study explores gender-related differences in patients hospitalized for acute heart failure

Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.

27 Aug 2012

Women with heart attack symptoms receive lower quality of care than men

A new study published recently in the American Journal of Medicine, conducted by researchers in the Cardiac and Vascular Institute at NYU Langone Medical Center, found there was significantly lower quality of care and worse outcomes in women compared to men - particularly young women under age 35 who had heart attack symptoms.

23 Aug 2012

Laminin-111 protein therapy could treat Duchenne muscular dystrophy

A novel treatment in development at the University of Nevada School of Medicine for the most common form of muscular dystrophy is advancing towards human trials with a $308,000 boost from the Muscular Dystrophy Association.

23 Aug 2012

Healthcare announces important changes to the U.S. product label for Optison

GE Healthcare today announced important changes to the U.S. product label for Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a contrast agent that may improve the visualization of the left ventricular border - an area of the heart that is critical to see in order to diagnose certain heart diseases such as hypertrophic cardiomyopathy.

22 Aug 2012

UCLA Medical Center receives platinum award for outstanding heart attack care

Ronald Reagan UCLA Medical Center has received an award for outstanding heart attack care from the American College of Cardiology Foundation called the NCDR ACTION Registry-GWTG Platinum Performance Achievement Award for 2012.

21 Aug 2012

WSU researchers to test novel hypothesis that cardiolipin deficiency leads to disruption of TCA cycle

Barth Syndrome (BTHS) is a rare and serious genetic disorder that primarily affects males and is passed from mother to son; women who are carriers do not show symptoms of the disorder. Fifty percent of children born to a mother who is a carrier will inherit the defective gene, and all daughters born to an affected man will be carriers. BTHS is caused by a mutation in the tafazzin gene that results in decreased production of cardiolipin, an essential lipid for energy metabolism.

8 Aug 2012

Study confirms link between sickle cell trait and deaths in young black competitive athletes

While some published research has hinted at the connection between the sickle cell trait and sudden cardiac death among young, athletic African-American males, which was initially observed in black military recruits 25 years ago, a new study with the first sizeable patient series definitively confirms this risk for these individuals during competitive sports.

26 Jul 2012

Rapamycin improves function and extends survival in mice with DCM and rare muscular dystrophies

Rapamycin, an immunosuppressant drug used in a variety of disease indications and under study in aging research labs around the world, improved function and extended survival in mice suffering from a genetic mutation which leads to dilated cardiomyopathy (DCM) and rare muscular dystrophies in humans.

26 Jul 2012

Research explains why exercise is beneficial for heart function in type 2 diabetes

A detailed study of heart muscle function in mice has uncovered evidence to explain why exercise is beneficial for heart function in type 2 diabetes. The research team, led by scientists at the Johns Hopkins University School of Medicine, found that greater amounts of fatty acids used by the heart during stressful conditions like exercise can counteract the detrimental effects of excess glucose and improve the diabetic heart's pumping ability in several ways.

18 Jul 2012

How does exercise improve heart function in diabetics?

A detailed study of heart muscle function in mice has uncovered evidence to explain why exercise is beneficial for heart function in type 2 diabetes.

18 Jul 2012

Positive results from Alnylam’s ALN-TTR02 Phase I trial on TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive clinical results from its Phase I trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis.

16 Jul 2012

Cleveland Clinic receives NHLBI grant to identify new pathways linked with cardiovascular diseases

The National Heart, Lung, and Blood Institute (NHLBI) has awarded a $4.78 million grant to researchers at Cleveland Clinic's Lerner Research Institute to use metabolomics - a new approach that focuses on the small-molecule byproducts of metabolism - for discovery of novel pathways linked to the development of cardiovascular diseases.

14 Jul 2012

Cardiomyopathy News and Research

Further Reading

Most women with heart disease can shun advice to avoid pregnancy

Plastic hearts still break

Friedreich Ataxia Research Alliance, USF ARC to host ‘Understanding a Cure’ symposium

Study explores gender-related differences in patients hospitalized for acute heart failure

Women with heart attack symptoms receive lower quality of care than men

Laminin-111 protein therapy could treat Duchenne muscular dystrophy

Healthcare announces important changes to the U.S. product label for Optison

UCLA Medical Center receives platinum award for outstanding heart attack care

WSU researchers to test novel hypothesis that cardiolipin deficiency leads to disruption of TCA cycle

Study confirms link between sickle cell trait and deaths in young black competitive athletes

Rapamycin improves function and extends survival in mice with DCM and rare muscular dystrophies

Research explains why exercise is beneficial for heart function in type 2 diabetes

How does exercise improve heart function in diabetics?

Positive results from Alnylam’s ALN-TTR02 Phase I trial on TTR-mediated amyloidosis

Cleveland Clinic receives NHLBI grant to identify new pathways linked with cardiovascular diseases

Experts call for add-on to athletes’ cardiac screening

Broken heart syndrome arms against epinephrine high

Broken heart syndrome arms against epinephrine high

Echocardiography can help identify athletes with heart problems at risk for sudden death

Conference highlights utility of zebrafish for human disorder studies

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News